Orthostatic hypotension is associated with incident chronic kidney disease: The Atherosclerosis Risk In Communities Study
暂无分享,去创建一个
[1] O. Melander,et al. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmö Preventive Project) , 2009, European heart journal.
[2] Karin Kraft,et al. [Type-2 diabetes]. , 2010, MMW Fortschritte der Medizin.
[3] A. Köttgen,et al. Defining incident chronic kidney disease in the research setting: The ARIC Study. , 2009, American journal of epidemiology.
[4] M. Esler,et al. Sympathetic activation in chronic renal failure. , 2009, Journal of the American Society of Nephrology : JASN.
[5] D. Goldstein,et al. Neurogenic Orthostatic Hypotension: A Pathophysiological Approach , 2009, Circulation.
[6] B. Wallin,et al. A sympathetic view of the sympathetic nervous system and human blood pressure regulation , 2008, Experimental physiology.
[7] R. Freeman,et al. Clinical practice. Neurogenic orthostatic hypotension. , 2008, The New England journal of medicine.
[8] C. Tseng,et al. Prevalence and severity of renal disease in familial dysautonomia. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] A. Sharrett,et al. Orthostatic Hypotension Predicts Mortality in Middle-Aged Adults: The Atherosclerosis Risk in Communities (ARIC) Study , 2006, Circulation.
[10] Y. Kida. Apolipoprotein E and progression of chronic kidney disease. , 2006, JAMA.
[11] P. Whelton,et al. Effect of Blood Pressure on Early Decline in Kidney Function Among Hypertensive Men , 2003, Hypertension.
[12] A. Sharrett,et al. Association between the blood pressure response to a change in posture and the 6-year incidence of hypertension: prospective findings from the ARIC study , 2002, Journal of Human Hypertension.
[13] C. Lang,et al. Increased Vascular Adrenergic Vasoconstriction and Decreased Vasodilation in Blacks: Additive Mechanisms Leading to Enhanced Vascular Reactivity , 2000, Hypertension.
[14] Daniel W. Jones,et al. Orthostatic Hypotension as a Risk Factor for Stroke: The Atherosclerosis Risk in Communities (ARIC) Study, 1987–1996 , 2000, Stroke.
[15] J. Coresh,et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.
[16] A. Sharrett,et al. Orthostatic hypotension and the incidence of coronary heart disease: the Atherosclerosis Risk in Communities study. , 2000, American journal of hypertension.
[17] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[18] M. Cirillo,et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. , 1998, Archives of internal medicine.
[19] A. Folsom,et al. Body weight change and carotid artery wall thickness. The Atherosclerosis Risk in Communities (ARIC) Study. , 1998, American journal of epidemiology.
[20] P. Whelton,et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. , 1997, JAMA.
[21] K. Iseki,et al. Blood pressure and risk of end-stage renal disease in a screened cohort. , 1996, Kidney international. Supplement.
[22] J. Jankovic,et al. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy , 2005, Clinical Autonomic Research.
[23] P. Whelton,et al. Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.
[24] A. Folsom,et al. Variability in B-mode ultrasound measurements in the atherosclerosis risk in communities (ARIC) study. , 1996, Ultrasound in medicine & biology.
[25] J. Miller,et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. , 1995, Hypertension.
[26] J J Smith,et al. Hemodynamic Response to the Upright Posture , 1994, Journal of clinical pharmacology.
[27] L. Chambless,et al. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities Study. , 1994, Archives of pathology & laboratory medicine.
[28] P. Whelton,et al. A Prospective Study of Blood Pressure and Serum Creatinine: Results From the 'Clue' Study and the ARIC Study , 1993 .
[29] R. Neuwirth,et al. Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group. , 1992, JAMA.
[30] L. Chambless,et al. Measuring Ankle Systolic Blood Pressure: Validation of the Dinamap 1846 SX , 1992, Angiology.
[31] L. Chambless,et al. High‐Resolution B‐Mode Ultrasound Reading Methods in the Atherosclerosis Risk in Communities (ARIC) Cohort , 1991, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[32] H. Dustan,et al. Renal insufficiency in treated essential hypertension. , 1989, The New England journal of medicine.